GDRXGoodRx Holdings, Inc.

$829M

Q2 2023 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$190M-1.1% YoY

Gross Profit

$173M91.4% margin

Operating Income

$18M9.7% margin

Net Income

$59M31.0% margin

EPS (Diluted)

$0.14

QoQ Revenue Growth

+3.1%

Cash Flow

Operating Cash Flow

$30M

Free Cash Flow

$15M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$797M

Stockholders' Equity

$895M

Cash & Equivalents

$762M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$190M	$192M	-1.1%
Gross Profit	$173M	$174M	-0.2%
Operating Income	$18M	-$4M	+552.4%
Net Income	$59M	-$1M	+4254.5%

Revenue Segments

Prescription Transactions Revenue

$137M72%

Pharma Manufacturer Solutions Revenues

$24M13%

Subscription Revenue

$24M13%

Other Revenue

$5M3%

GDRX Q2 2023 Earnings — GoodRx Holdings, Inc. Revenue & Financial Results | Market Cap Arena